Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer

Journal of the National Cancer Institute

Volumn 106, Issue 10, 2014, Pages

  Kehl, Kenneth L ^a   Arora, Neeraj K ^b   Schrag, Deborah ^c   Ayanian, John Z ^d,g   Clauser, Steven B ^b   Klabunde, Carrie N ^b   Kahn, Katherine L ^e,f   Fletcher, Robert H ^g   Keating, Nancy L ^a,g  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f RAND CORPORATION   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; ASIAN AMERICAN; CANCER CHEMOTHERAPY; CANCER STAGING; CAUCASIAN; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; COLORECTAL CANCER; COLORECTAL TUMOR; COMORBIDITY; DECISION MAKING; DIAGNOSIS; FEMALE; HEALTH SURVEY; HUMAN; INCOME; INFORMATION SEEKING; INTERPERSONAL COMMUNICATION; LUNG CANCER; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATHOLOGY; PATIENT PARTICIPATION; PATIENT SELECTION; PRIORITY JOURNAL; QUESTIONNAIRE; RACE DIFFERENCE; SENSITIVITY ANALYSIS; SOCIOECONOMICS; STATISTICS; THERAPY; UNITED STATES; VERY ELDERLY;

AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN AMERICANS; CHOICE BEHAVIOR; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; COLORECTAL NEOPLASMS; COMMUNICATION; COMORBIDITY; DECISION MAKING; DIAGNOSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCOME; INFORMATION SEEKING BEHAVIOR; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATHOLOGY; PATIENT PARTICIPATION; PATIENT SELECTION; QUESTIONNAIRES; STATISTICS AND NUMERICAL DATA; THERAPY; UNITED STATES;

EID: 84930406726     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju216     Document Type: Article

References (34)

1. Nass SJ, Moses HL, Mendelsohn J. A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program.. Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine, National Academies Press; 2010:1371.
2. Schroen AT, Petroni GR, Wang H, et al. Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U. S. Cooperative Oncology Groups. Clin Cancer Res. 2012;18(1):256-262.
3. Fouad MN, Lee JY, Catalano PJ, et al. Enrollment of patients with lung and colorectal cancers onto clinical trials. J Oncol Pract. 2013;9(2):e40-e47.
4. Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007;14(12):3328-3334.
5. Unger JM, Hershman DL, Albain KS, et al. Patient income level and cancer clinical trial participation. J Clin Oncol. 2013;31(5):536-542.
6. Jimenez R, Zhang B, Joffe S, et al. Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment? J Palliat Med. 2013;16(3):256-262.
7. Kennedy BJ. Needed: clinical trials for older patients. J Clin Oncol. 1991;9(5):718-720.
8. Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341(27):2061-2067.
9. Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol. 2004;22(22):4626-4631.
10. Du W, Gadgeel SM, Simon MS. Predictors of enrollment in lung cancer clinical trials. Cancer. 2006;106(2):420-425.
11. Albrecht TL, Eggly SS, Gleason MEJ, et al. Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol. 2008;26(16):2666-2673.
12. Ayanian JZ, Chrischilles EA, Fletcher RH, et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol. 2004;22(15):2992-2996.
13. Catalano PJ, Ayanian JZ, Weeks JC, et al. Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program. Med Care. 2013;51(2):e9-e15.
14. The American Association for Public Opinion Research (AAPOR). Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. 5th ed. Lenexa, Kansas; 2008.
15. Malin JL, Ko C, Ayanian JZ, et al. Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer. 2006;14(8):837-848.
16. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996;34(1):73-84.
17. Klabunde CN, Reeve BB, Harlan LC, Davis WW, Potosky AL. Do patients consistently report comorbid conditions over time?: results from the prostate cancer outcomes study. Med Care. 2005;43(4):391-400.
18. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233.
19. Greene FL, Page DL, Fleming ID, eds. AJCC Cancer Staging Manual. 6th. ed. New York: Springer; 2002.
20. Jacobson CK. Denominational and Racial and Ethnic Differences in Fatalism. Rev Relig Res. 1999;41(1):9-20.
21. Degner LF, Sloan JA, Venkatesh P. The Control Preferences Scale. Can J Nurs Res. 1997;29(3):21-43.
22. Degner LF, Kristjanson LJ, Bowman D, et al. Information needs and decisional preferences in women with breast cancer. JAMA. 1997;277(18):1485-1492.
23. Keating NL, Landrum MB, Arora NK, et al. Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol. 2010;28(28):4364-4370.
24. He Y, Zaslavsky AM, Landrum MB, Harrington DP, Catalano P. Multiple imputation in a large-scale complex survey: a practical guide. Stat Methods Med Res. 2010;19(6):653-670.
25. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291(22):2720-2726.
26. Kanarek NF, Tsai H-L, Metzger-Gaud S, et al. Geographic proximity and racial disparities in cancer clinical trial participation. J Natl Compr Canc Netw. 2010;8(12):1343-1351.
27. Eggly S, Barton E, Winckles A, Penner LA, Albrecht TL. A disparity of words: racial differences in oncologist-patient communication about clinical trials. Health Expect. 2013. doi: 10.1111/hex.12108.
28. Javid SH, Unger JM, Gralow JR, et al. A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316). Oncologist. 2012;17(9):1180-1190.
29. Légaré F, Ratté S, Stacey D, et al. Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Database Syst Rev. 2010;(5): CD006732.
30. Stacey D, Bennett CL, Barry MJ, et al. Decision aids for people facing health treatment or screening decisions. Cochrane database Syst Rev. 2011;(10): CD001431.
31. Edwards A, Elwyn G, Hood K, et al. Patient-based outcome results from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice. Fam Pract. 2004;21(4):347-354.
32. Tak HJ, Ruhnke GW, Meltzer DO. Association of patient preferences for participation in decision making with length of stay and costs among hospitalized patients. JAMA Intern Med. 2013;173(13):1195-1205.
33. Lara PN, Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001;19(6):1728-1733.
34. Go RS, Frisby KA, Lee JA, et al. Clinical trial accrual among new cancer patients at a community-based cancer center. Cancer. 2006;106(2):426-433.